Tactile Systems Technology Management
Management criteria checks 2/4
Tactile Systems Technology's CEO is Dan Reuvers, appointed in Jun 2020, has a tenure of 3.83 years. total yearly compensation is $2.87M, comprised of 22.6% salary and 77.4% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth $1.00M. The average tenure of the management team and the board of directors is 1.2 years and 2.3 years respectively.
Key information
Dan Reuvers
Chief executive officer
US$2.9m
Total compensation
| CEO salary percentage | 22.6% |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.3% |
| Management average tenure | 1.2yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
Tactile Systems Technology, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 23
Does Tactile Systems Technology (NASDAQ:TCMD) Have A Healthy Balance Sheet?
Oct 10Capital Allocation Trends At Tactile Systems Technology (NASDAQ:TCMD) Aren't Ideal
Sep 16Is It Time To Consider Buying Tactile Systems Technology, Inc. (NASDAQ:TCMD)?
Jul 13Are Investors Undervaluing Tactile Systems Technology, Inc. (NASDAQ:TCMD) By 26%?
May 10Is Tactile Systems Technology (NASDAQ:TCMD) Using Too Much Debt?
Feb 16Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?
Oct 12Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M
Aug 01Is Tactile Systems Technology (NASDAQ:TCMD) A Risky Investment?
Jun 14Investors Could Be Concerned With Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital
Jan 20Some Investors May Be Worried About Tactile Systems Technology's (NASDAQ:TCMD) Returns On Capital
May 20Tactile Systems Technology EPS beats by $0.03, beats on revenue
May 03Have Tactile Systems Technology, Inc. (NASDAQ:TCMD) Insiders Been Selling Their Stock?
Mar 04Is Tactile Systems Technology (NASDAQ:TCMD) Likely To Turn Things Around?
Feb 19Can You Imagine How Tactile Systems Technology's (NASDAQ:TCMD) Shareholders Feel About The 44% Share Price Increase?
Dec 28
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$650k | US$29m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$356k |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$3m | US$625k | -US$18m |
| Sep 30 2022 | n/a | n/a | -US$30m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$25m |
| Dec 31 2021 | US$2m | US$571k | -US$12m |
| Sep 30 2021 | n/a | n/a | US$8m |
| Jun 30 2021 | n/a | n/a | US$14m |
| Mar 31 2021 | n/a | n/a | -US$2m |
| Dec 31 2020 | US$2m | US$296k | -US$620k |
Compensation vs Market: Dan's total compensation ($USD2.87M) is about average for companies of similar size in the US market ($USD2.36M).
Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.
CEO
Dan Reuvers (60 yo)
3.8yrs
Tenure
US$2,874,593
Compensation
Mr. Daniel L. Reuvers, also known as Dan, has been President, Chief Executive Officer and Director of Tactile Systems Technology, Inc. since June 8, 2020. He served as Executive Vice President and Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$2.87m | 0.29% $ 1.0m | |
| Chief Financial Officer | 1.1yrs | US$1.44m | 0% $ 0 | |
| Senior Vice President of Marketing & Clinical Affairs | 3.1yrs | US$987.00k | 0.069% $ 235.3k | |
| Senior Vice President of Sales | less than a year | US$771.98k | no data | |
| Senior Vice President of Manufacturing | no data | no data | no data | |
| Chief Information Officer | less than a year | no data | no data | |
| VP & Compliance Officer | no data | no data | no data | |
| Chief Human Resource Officer | 2.3yrs | no data | no data | |
| Chief Medical Officer & Member of Vascular Strategic Advisory Board | 1.3yrs | no data | no data | |
| Senior Vice President of Commercial Operations | less than a year | no data | no data |
1.2yrs
Average Tenure
Experienced Management: TCMD's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$2.87m | 0.29% $ 1.0m | |
| Chief Medical Officer & Member of Vascular Strategic Advisory Board | no data | no data | no data | |
| Independent Director | 1.3yrs | no data | 0.014% $ 49.1k | |
| Independent Director | 6.6yrs | US$214.99k | 0.093% $ 316.9k | |
| Independent Chairman | 8.6yrs | US$249.99k | 0.084% $ 288.1k | |
| Independent Director | 2.3yrs | US$216.24k | 0.061% $ 209.1k | |
| Member of Vascular Strategic Advisory Board | no data | no data | no data | |
| Independent Director | 3.3yrs | US$209.37k | 0.065% $ 222.1k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Chairman of Vascular Strategic Advisory Board | 1.3yrs | no data | no data | |
| Independent Director | 2.3yrs | US$258.37k | 0.061% $ 209.1k | |
| Member of Vascular Strategic Advisory Board | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
62yo
Average Age
Experienced Board: TCMD's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.